These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9445759)

  • 1. Consensus on future directions in Parkinson's disease research.
    Glaser V
    Mol Med Today; 1995 Nov; 1(8):350. PubMed ID: 9445759
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease: a neurodegenerative disease particularly amenable to gene therapy.
    Bohn MC
    Mol Ther; 2000 Jun; 1(6):494-6. PubMed ID: 10933972
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy progress and prospects: Parkinson's disease.
    Burton EA; Glorioso JC; Fink DJ
    Gene Ther; 2003 Sep; 10(20):1721-7. PubMed ID: 12939638
    [No Abstract]   [Full Text] [Related]  

  • 4. Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease.
    Lapchak PA; Miller PJ; Jiao S; Araujo DM; Hilt D; Collins F
    Neurodegeneration; 1996 Sep; 5(3):197-205. PubMed ID: 8910897
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene therapy to the rescue in Parkinson's disease.
    Mandir AS; Dawson VL; Dawson TM
    Trends Pharmacol Sci; 2001 Mar; 22(3):103-5; discussion 105-6. PubMed ID: 11239561
    [No Abstract]   [Full Text] [Related]  

  • 6. Glial cell line-derived neurotrophic factor (GDNF) prevents neurodegeneration in models of Parkinson's disease.
    Reilly CE
    J Neurol; 2001 Jan; 248(1):76-8. PubMed ID: 11266028
    [No Abstract]   [Full Text] [Related]  

  • 7. New movement in Parkinson's.
    Lozano AM; Kalia SK
    Sci Am; 2005 Jul; 293(1):68-75. PubMed ID: 16008304
    [No Abstract]   [Full Text] [Related]  

  • 8. Parkinson disease gene therapy moves toward the clinic.
    Björklund A; Lindvall O
    Nat Med; 2000 Nov; 6(11):1207-8. PubMed ID: 11062522
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene therapy to the rescue in Parkinson's disease. Response from Kordower and Aebischer.
    Kordower JH; Aebischer P
    Trends Pharmacol Sci; 2001 Mar; 22(3):105-6. PubMed ID: 11239562
    [No Abstract]   [Full Text] [Related]  

  • 10. Viral vectors in the treatment of Parkinson's disease.
    Latchman DS; Coffin RS
    Mov Disord; 2000 Jan; 15(1):9-17. PubMed ID: 10634236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease.
    Sullivan AM; Pohl J; Blunt SB
    Eur J Neurosci; 1998 Dec; 10(12):3681-8. PubMed ID: 9875347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson's disease.
    Lapchak PA; Gash DM; Jiao S; Miller PJ; Hilt D
    Exp Neurol; 1997 Mar; 144(1):29-34. PubMed ID: 9126148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GDNF treatment in Parkinson's disease: time for controlled clinical trials?
    Brundin P
    Brain; 2002 Oct; 125(Pt 10):2149-51. PubMed ID: 12244075
    [No Abstract]   [Full Text] [Related]  

  • 14. A gene therapy approach for the treatment of amyotrophic lateral sclerosis and Parkinson's disease.
    Zurn AD; Tseng JL; Déglon N; Joseph JM; Aebischer P
    Adv Pharmacol; 1998; 42():929-31. PubMed ID: 9328050
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glial cell line-derived neurotrophic factor for the rescue of dopaminergic neurons in Parkinson's disease].
    Honma Y; Kohsaka S
    No To Shinkei; 2003 Oct; 55(10):847-53. PubMed ID: 14635513
    [No Abstract]   [Full Text] [Related]  

  • 16. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts.
    Rosenblad C; Martinez-Serrano A; Björklund A
    Neuroscience; 1996 Dec; 75(4):979-85. PubMed ID: 8938733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal transplantation and neurotrophic factors in the treatment of Parkinson's disease--update February 1995.
    Kupsch A; Oertel WH; Earl CD; Sautter J
    J Neural Transm Suppl; 1995; 46():193-207. PubMed ID: 8821056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Movement disorders: Parkinson's disease dominates.
    Pollak P
    Lancet Neurol; 2004 Jan; 3(1):15. PubMed ID: 14693104
    [No Abstract]   [Full Text] [Related]  

  • 19. Experiments in a Parkinson's rat model.
    Pallini R; Consales A; Lauretti L; Fernandez E
    Science; 1997 Jul; 277(5324):389-90. PubMed ID: 9518368
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological activities of glial cell line-derived neurotrophic factor (GDNF): preclinical development and application to the treatment of Parkinson's disease.
    Lapchak PA; Gash DM; Collins F; Hilt D; Miller PJ; Araujo DM
    Exp Neurol; 1997 Jun; 145(2 Pt 1):309-21. PubMed ID: 9217068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.